Skip to main content
HR 2051 109th Congress House Health Coinsurance Employee health benefits Finance and Financial Sector Health insurance Hospital care Immunosuppressive drugs Insurance premiums Kidney diseases Labor and Employment Medical economics Medicare Social Welfare Transplantation of organs, tissues, etc.

Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2005

Introduced: May 3, 2005 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 20, 2005
Referred to the Subcommittee on Employer-Employee Relations.
May 13, 2005
Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.
May 10, 2005
Referred to the Subcommittee on Health.
May 3, 2005
Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 3, 2005
Introduced in House
 Plain-English summary Congressional Research Service

Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2005 - Amends title II (Old Age, Survivors and Disability Insurance)(OASDI) of the Social Security Act (SSA) to eliminate the time limitations for coverage of immunosuppressive drugs for individuals who receive a kidney transplant or other organ transplant.

Amends title XVIII (Medicare ) of SSA to apply special rules to individuals receiving additional coverage for immunosuppressive drugs, including: (1) that such individual is deemed to be enrolled under Medicare part B for purposes of receiving such coverage; (2) that such individual is responsible for the full amount of the applicable premiums; and (3) that deductible and coinsurance amounts apply. Requires the Secretary of Health and Human Services to establish procedures for implementing such coverage.

Extends Medicare secondary payer requirements for end stage renal disease beneficiaries.

Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to require a group health plan or issuer to provide coverage of immunosuppressive drugs that is at least as comprehensive as coverage provided on the date of enactment of this Act.

What's happening now May 20, 2005

Referred to the Subcommittee on Employer-Employee Relations.

 Committees of jurisdiction 6
 Cosponsors 1
All 1 Republican 1